Use of a method for acting on proteins in the diagnosis and treatment of diseases associated with mutations in the KRAS gene

CN115058519BActive Publication Date: 2026-08-28张弩
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
CN202210904966.2
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-07-29
Publication Date
2026-08-28
Estimated Expiration
2042-07-29

AI Technical Summary

Technical Problem

KRAS基因突变96%发生在第2号外显子的12、13号密码子,这些KRAS突变型编码异常的蛋白,刺激促进恶性肿瘤细胞的生长和扩散;并且不受上游EGFR的信号影响,所以针对KRAS基因突变的患者,通常对其使用EGFR抑制剂的治疗效果差,甚至无治疗效果

Benefits of technology

[0057]本发明的有益效果为,以蛋白为作用对象的方法在诊断和治疗KRAS基因突变相关疾病中的应用,其中的蛋白(RASON)已被证实会在恶性肿瘤、尤其是KRAS基因突变诱导的恶性肿瘤中过表达,因此,将该蛋白应用于诊断、治疗恶性肿瘤的产品中,能够有效的利用其自身特性对恶性肿瘤进行诊断和治疗,市场应用前景广阔。

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN115058519B_ABST
    Figure CN115058519B_ABST
Patent Text Reader

Abstract

The application provides an application of a method taking a protein as an action object in diagnosis and treatment of a KRAS gene mutation related disease, the method is to detect the expression of the protein to achieve the purpose of diagnosing the disease, or to inhibit or eliminate the activity of the protein, reduce or remove the protein to achieve the purpose of treating the disease. The application has the beneficial effect that the application of the method taking the protein as the action object in diagnosis and treatment of the KRAS gene mutation related disease, wherein the protein (RASON) has been proved to be overexpressed in a malignant tumor, especially a malignant tumor induced by the KRAS gene mutation, therefore, the protein is applied to a product for diagnosing and treating the malignant tumor, can effectively utilize the self characteristics to diagnose and treat the malignant tumor, and has wide market application prospect.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Application of long non-coding RNA LINC00673

    CN106480030A

  • Application of siRNA of long non-coding RNA LINC00673 and inhibition preparation

    CN106492228A

  • Biological marker for diagnosing and treating liver cancer

    CN106834528A

  • lncRNA detection kit for diagnosing lung cancer metastasis and application thereof

    CN109055556A

  • IncRNA detection kit for early diagnosis of lung cancer metastasis and application of IncRNA detection kit

    CN109136373A